This result suggested the NFE2L2, KEAP1 and RASA1 relevant expressional heterogeneity and the corresponding prognostic influences mainly hold true in LUSC patients, but not for the other types of lung cancers. The gene discussed is NFE2L2; the disease is lung carcinoma.